A

Anika Therapeutics
D

ANIK

16.970
USD
-0.49
(-2.81%)
Market Closed
Volume
1,467
EPS
1
Div Yield
-
P/E
-3
Market Cap
248,535,764
OverviewSignalsIdeasNews
Related Instruments
    ABT
    ABT
    0.850
    (0.74%)
    117.74 USD
    B
    BAX
    0.260
    (0.82%)
    31.970 USD
    BDX
    BDX
    -2.040
    (-0.90%)
    225.190 USD
    BSX
    BSX
    -0.590
    (-0.67%)
    87.000 USD
    EW
    EW
    1.620
    (2.45%)
    67.780 USD
    ISRG
    ISRG
    -10.30
    (-1.92%)
    547.83 USD
    MDT
    MDT
    1.520
    (1.77%)
    86.2 USD
    SYK
    SYK
    6.90
    (1.80%)
    384.88 USD
    TMO
    TMO
    -19.95
    (-3.74%)
    513.04 USD
    Z
    ZBH
    3.638
    (3.34%)
    112.490 USD
    More
News

Title: Anika Therapeutics

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.